Trials / Completed
CompletedNCT00880581
A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas
A Phase 2 Study of Intratumoral Injection PF-3512676 in Combination With Local Radiation in Low-Grade B-Cell Lymphomas
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Ronald Levy · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the feasibility of using intra-tumoral PF-3512676 in combination with local radiation as a therapy for lowgrade b-cell lymphoma.
Conditions
- Lymphoma, Non-Hodgkin
- Lymphoma
- Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell
- Lymphomas: Non-Hodgkin
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PF-3512676 | 18 mg injection |
| RADIATION | Local radiotherapy | 2 gray (2 Gy) on each of Days 1 and 2 |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2011-09-01
- Completion
- 2015-01-01
- First posted
- 2009-04-14
- Last updated
- 2017-03-14
- Results posted
- 2017-03-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT00880581. Inclusion in this directory is not an endorsement.